Sale!

KRAS Codon 61 Mutation Detection Test Cost

Original price was: 1,620 د.إ.Current price is: 1,460 د.إ.

-10%

The KRAS Codon 61 Mutation Detection Test is a specialized diagnostic procedure aimed at identifying mutations in codon 61 of the KRAS gene. These mutations are significant because they can play a crucial role in the development and progression of various types of cancer, including colorectal, lung, and pancreatic cancers. By pinpointing these specific genetic alterations, the test aids in determining the most effective treatment strategies for patients, potentially guiding the use of targeted therapies that are more likely to be effective against tumors harboring these mutations.

Performed at DNA Labs UAE, a leading facility in genetic testing, the test leverages advanced molecular techniques to accurately detect the presence of mutations in the KRAS gene. The cost of the KRAS Codon 61 Mutation Detection Test at DNA Labs UAE is 1460 AED. This price reflects the sophisticated technology and expertise required to conduct such a precise genetic analysis. For patients and healthcare providers, the test represents a valuable tool in the personalized medicine approach, offering insights that can significantly impact treatment decisions and outcomes in cancer care.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

KRAS CODON 61 MUTATION DETECTION Test

Welcome to DNA Labs UAE, where we offer the KRAS CODON 61 MUTATION DETECTION Test. This diagnostic test is used to identify mutations in the KRAS gene at codon 61.

Test Details

The KRAS codon 61 mutation detection test is a diagnostic test used to identify mutations in the KRAS gene at codon 61. The KRAS gene is involved in regulating cell growth and division, and mutations in this gene can lead to uncontrolled cell growth and the development of certain types of cancer, such as colorectal cancer.

Test Components and Price

The test is priced at 1460.0 AED. To perform the test, we require a fresh tissue sample in normal saline or a formalin-fixed paraffin-embedded block. The fresh tissue should be shipped refrigerated within 72 hours and should have at least 10% tumor tissue. Additionally, a duly filled NGS Test Requisition Form is mandatory.

Report Delivery

The sample should be submitted by 11 am, and the report will be delivered within 15 days.

Method and Test Type

The KRAS codon 61 mutation detection test is performed using the PCR method. It falls under the category of cancer tests.

Referring Doctor and Test Department

This test is commonly referred by Oncologists and is conducted in our Molecular Diagnostics department.

Pre Test Information

A duly filled NGS Test Requisition Form is mandatory for this test.

Importance of the Test

The detection of a KRAS codon 61 mutation can have important implications for treatment decisions. Certain targeted therapies may be more effective in patients with specific KRAS mutations. For example, patients with KRAS codon 61 mutations may be less likely to respond to certain anti-EGFR therapies. The KRAS codon 61 mutation detection test helps healthcare providers personalize cancer treatment by identifying specific genetic mutations that may impact treatment options and outcomes.

Test Name KRAS CODON 61 MUTATION DETECTION Test
Components
Price 1460.0 AED
Sample Condition Submit fresh tissue in normal saline OR formalin fixed paraffin embedded block. Ship fresh tissue refrigerated within 72 hours. Block should have at least 10% tumor tissue. Duly filled NGS Test Requisition Formis mandatory.
Report Delivery SampleSat by 11 am; Report 15 days
Method PCR
Test type Cancer
Doctor Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Duly filled NGS Test Requisition Formis mandatory.
Test Details

The KRAS codon 61 mutation detection test is a diagnostic test used to identify mutations in the KRAS gene at codon 61. The KRAS gene is involved in regulating cell growth and division, and mutations in this gene can lead to uncontrolled cell growth and the development of certain types of cancer, such as colorectal cancer.

The test is typically performed on a tissue sample, such as a biopsy or surgical specimen, from a suspected cancerous lesion. The sample is analyzed in a laboratory to determine if there are any mutations present in the KRAS gene at codon 61.

The detection of a KRAS codon 61 mutation can have important implications for treatment decisions, as certain targeted therapies may be more effective in patients with specific KRAS mutations. For example, patients with KRAS codon 61 mutations may be less likely to respond to certain anti-EGFR therapies.

Overall, the KRAS codon 61 mutation detection test helps healthcare providers personalize cancer treatment by identifying specific genetic mutations that may impact treatment options and outcomes.